Elevance Health, Inc. (ELV)
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Open Elevance Health, Inc. in the interactive graph- Ticker
- ELV
- SEC CIK
- 0001156039
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Periods
- FY2025 Q1, FY2025 Q4, FY2026, FY2026 Q1, FY2026 Q3, FY2027
- Headquarters
- Indianapolis, IN
- Employees
- 96,129
Key figures
- Revenue 41.02B USD
- NetIncome 1.76B USD
- DilutedEPS 8.00 USD/share
Reported figures
- CapitalExpenditure 196.00M USD
- CapitalExpenditure 235.00M USD
- CashAndEquivalents 2.20B USD
- CashAndEquivalents 7.50B USD
- CashAndEquivalents 9.49B USD
- CashAndEquivalents 9.66B USD
- CostOfRevenue 4.98B USD
- CostOfRevenue 5.46B USD
- DilutedEPS 11.97 USD/share
- DilutedEPS 12.58 USD/share
- DilutedEPS 8.00 USD/share
- DilutedEPS 9.61 USD/share
- DividendPerShare 1.72 USD/share
- FreeCashFlow 4.10B USD
- GrossProfit 9.10B USD
- InterestExpense 344.00M USD
- InterestExpense 357.00M USD
- InterestIncome 590.00M USD
- InterestIncome 765.00M USD
- NetIncome 1.76B USD
- NetIncome 2.18B USD
- NetIncome 2.72B USD
- NetIncome 2.77B USD
- OperatingCashFlow 1.02B USD
- OperatingCashFlow 4.30B USD
- OperatingCashFlow 4.33B USD
- OperatingExpenses 5.21B USD
- OperatingExpenses 5.30B USD
- OperatingExpenses 6.33B USD
- OperatingIncome 1.10B USD
- OperatingIncome 2.09B USD
- OperatingIncome 2.10B USD
- OperatingIncome 2.16B USD
- OperatingIncome 2.22B USD
- OperatingIncome 2.66B USD
- OperatingIncome 3.17B USD
- OperatingIncome 3.20B USD
- OperatingIncome 3.25B USD
- OperatingIncome 3.30B USD
- OperatingIncome 470.00M USD
- and 58 more in the interactive graph
Guidance
- DilutedEPS guidance 19.85 USD/share
- DilutedEPS guidance 26.75 USD/share
- OperatingCashFlow guidance 5.50B USD
Drivers
- $935 million accrual for CMS matter related to Medicare Advantage risk adjustment data inc
- Anticipated declines in Medicare Advantage, Medicaid, and Employer Group risk membership p
- Anticipated reductions in Medicare Advantage and Employer Group risk membership as company
- Continued investment in expansion of risk-based capabilities in Carelon Services business
- Disciplined expense management decreased adjusted operating expense ratio by 20 basis poin
- Expansion of commercial fee-based membership increased medical membership
- Expected elevated medical cost trend in Medicaid business increased benefit expense ratio
- Growth in CarelonRx product revenue contributed to operating revenue increase
- Higher premium yields in Health Benefits segment drove operating revenue growth
- Improved performance in Medicare partially offset benefit expense ratio increase
- Improved profitability in specialty pharmacy and behavioral health businesses partially of
- Lower health plan membership negatively impacted Carelon operating gain
- Non-recurring investment income contributed approximately $1 per share to adjusted diluted
- Scaling of Carelon Services risk-based solutions drove revenue growth
- Underlying business strength and favorable working capital dynamics increased operating ca
Risks
- Identified potential exposure related to CMS notice for certain historical Medicare Advant
- Potential cash payments for the CMS matter may impact operating cash flow
Corporate events
- Business optimization program charges of $129 million to simplify and enhance organization
- Declared second quarter 2026 dividend of $1.72 per share, payable on June 25, 2026 to shar
- Repurchased 3.7 million shares of common stock for $1.1 billion at a weighted average pric
Quotes
- “Our first quarter results exceeded expectations, reflecting underlying business …”